Crispr Therapeutics AG
Ownership
Ownership Structure
Who owns Crispr Therapeutics AG (CRSP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.5% of the shares are freely tradable; institutional investors hold 79.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Investment Management LLC | 9.78 | 9,460,939 | -16.4 | 06/30/2026 |
| BlackRock Inc | 8.63 | 8,348,977 | +8.7 | 06/30/2026 |
| Orbis Allan Gray Ltd | 5.64 | 5,449,161 | -10.8 | 06/30/2026 |
| Capital World Investors | 4.91 | 4,749,525 | +0.5 | 06/30/2026 |
| State Street Corp | 4.47 | 4,321,666 | +8.5 | 06/30/2026 |
| GSK PLC | 3.33 | 3,220,627 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 2.60 | 2,509,915 | +5.6 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 6.60 | 6,378,377 | -7.3 | 09/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.83 | 2,734,112 | -1.9 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.41 | 2,325,509 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kulkarni Samarth | Chief Executive Officer | 311,899 | 16,031,609 $ | Oct 19, 2026 | direct |
| Kasinger James R. | General Counsel and Secretary | 95,857 | 4,927,050 $ | Oct 14, 2026 | direct |
| Behbahani Ali | Director | 16,666 | 856,632 $ | Aug 6, 2025 | both |
| George Simeon | Director | 15,486 | 795,980 $ | Oct 14, 2026 | direct |
| Prasad Raju | Chief Financial Officer | 14,815 | 761,491 $ | Aug 7, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 47,837 | 49.78 | 2,381,326 |
| Oct 16, 2026 | Kulkarni Samarth | Chief Executive Officer | Other | 100,000 | – | – |
| Oct 14, 2026 | George Simeon | Director | Sell | 14,514 | 49.63 | 720,373 |
| Oct 14, 2026 | George Simeon | Director | Other | 30,000 | 14.00 | 420,000 |
| Oct 14, 2026 | Kasinger James R. | General Counsel and Secretary | Sell | 1,040 | 49.26 | 51,230 |
| Oct 14, 2026 | Kulkarni Samarth | Chief Executive Officer | Sell | 4,098 | 49.26 | 201,867 |
| Oct 13, 2026 | Kasinger James R. | General Counsel and Secretary | Other | 2,113 | – | – |
| Oct 13, 2026 | Kulkarni Samarth | Chief Executive Officer | Other | 8,333 | – | – |
| Oct 6, 2026 | Kasinger James R. | General Counsel and Secretary | Sell | 1,990 | 60.04 | 119,481 |
| Oct 6, 2026 | Kasinger James R. | General Counsel and Secretary | Other | 1,990 | 13.62 | 27,104 |
| Sep 22, 2026 | Kasinger James R. | General Counsel and Secretary | Sell | 10,400 | 60.24 | 626,460 |
| Sep 22, 2026 | Kasinger James R. | General Counsel and Secretary | Other | 10,400 | 13.62 | 141,648 |
| Sep 17, 2026 | Behbahani Ali | Director | Sell | 13,679 | 57.09 | 780,935 |
| Sep 17, 2026 | Behbahani Ali | Director | Other | 30,000 | 14.00 | 420,000 |
| Aug 7, 2026 | Prasad Raju | Chief Financial Officer | Other | 750 | 0.00 | – |
| Aug 6, 2025 | Behbahani Ali | Director | Other | 15 | 0.00 | – |
| Aug 6, 2025 | Behbahani Ali | Director | Other | 60 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.